Overview
Concord Drugs Limited is a prominent pharmaceutical company in India, established in 1995, focusing on manufacturing various pharmaceutical formulations including injectables, tablets, and capsules.
The company operates two government-licensed manufacturing facilities equipped with advanced technology to ensure high-quality pharmaceutical production standards.
Concord Drugs has diversified its offerings by including innovative drug delivery technologies like MUPS and sustained release pellets, enhancing its product portfolio.
With a focus on contract manufacturing, Concord Drugs provides comprehensive pharmaceutical development, optimizing manufacturing services for diverse drug products.
- Sector
Pharmaceuticals & Biotechnology
- Industry
Pharmaceuticals
- Market Cap
103 Cr
- Volatility
Low Risk
- P/E Ratio
97.6
- Industry P/E
34.1
- PEG Ratio
0.7
- P/B Ratio
2.1
- 52W High
92.52
- 52W Low
29.00
Financial Ratios
Sales CAGR
- 1Y
- 0.71%
- 3Y
- -14.44%
- 5Y
- -6.38%
- 10Y
- -3.46%
Profit CAGR
- 1Y
- -27.66%
- 3Y
- -42.97%
- 5Y
- -2.07%
- 10Y
- -17.92%
ROE
- TTM
- 2.17%
- 3Y
- 1.61%
- 5Y
- 4.19%
- 10Y
- 3.71%
ROCE
- TTM
- 5.12%
- 3Y
- 6.49%
- 5Y
- 9.48%
- 10Y
- 10.14%
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
